Kim IY - Search Results

1

Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.

Kundu SD, Kim IY, Yang T, Doglio L, Lang S, Zhang X, Buttyan R, Kim SJ, Chang J, Cai X, Wang Z, Lee C. Kundu SD, et al. Among authors: kim iy, kim sj. Prostate. 2000 May 1;43(2):118-24. doi: 10.1002/(sici)1097-0045(20000501)43:2<118::aid-pros6>3.0.co;2-v. Prostate. 2000. PMID: 10754527

2

Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-beta 1.

Nemeth JA, Sensibar JA, White RR, Zelner DJ, Kim IY, Lee C. Nemeth JA, et al. Among authors: kim iy. Prostate. 1997 Sep 15;33(1):64-71. doi: 10.1002/(sici)1097-0045(19970915)33:1<64::aid-pros11>3.0.co;2-j. Prostate. 1997. PMID: 9294629

3

The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.

Kim IY, Zelner DJ, Lee C. Kim IY, et al. Exp Cell Res. 1998 May 25;241(1):151-60. doi: 10.1006/excr.1998.4034. Exp Cell Res. 1998. PMID: 9633523

4

Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.

Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C. Kim IY, et al. Among authors: kim jh. Cancer Res. 1996 Jan 1;56(1):44-8. Cancer Res. 1996. PMID: 8548772

5

Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.

Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C. Kim IY, et al. Among authors: kim jh. Exp Cell Res. 1996 Jan 10;222(1):103-10. doi: 10.1006/excr.1996.0013. Exp Cell Res. 1996. PMID: 8549651

6

Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression.

Kim IY, Ahn HJ, Zelner DJ, Park L, Sensibar JA, Lee C. Kim IY, et al. Mol Endocrinol. 1996 Jan;10(1):107-15. doi: 10.1210/mend.10.1.8838150. Mol Endocrinol. 1996. PMID: 8838150

7

Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients.

Kim IY, Ahn HJ, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, Lee C. Kim IY, et al. Clin Cancer Res. 1998 Jul;4(7):1625-30. Clin Cancer Res. 1998. PMID: 9676836

8

Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.

Kundu SD, Kim IY, Zelner D, Janulis L, Goodwin S, Engel JD, Lee C. Kundu SD, et al. Among authors: kim iy. J Urol. 1998 Nov;160(5):1883-8. J Urol. 1998. PMID: 9783979

9

Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.

Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C. Kim IY, et al. Clin Cancer Res. 1996 Aug;2(8):1255-61. Clin Cancer Res. 1996. PMID: 9816295

10

Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.

Kim IY, Kim JH, Zelner DJ, Ahn HJ, Sensibar JA, Lee C. Kim IY, et al. Among authors: kim jh. Endocrinology. 1996 Mar;137(3):991-9. doi: 10.1210/endo.137.3.8603613. Endocrinology. 1996. PMID: 8603613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,129 results

Search Page

Filters